Efficacy of Acupuncture-Related Therapy for Migraine: A Systematic Review and Network Meta-Analysis
Yinqin Liu,Yan Wang,Chuanhao Mi,Ziyue Wang,Yu Han,Xianghua Qi,Xiao Ding
DOI: https://doi.org/10.2147/jpr.s452971
IF: 2.8319
2024-03-16
Journal of Pain Research
Abstract:Yinqin Liu, 1 Yan Wang, 2 Chuanhao Mi, 1 Ziyue Wang, 1 Yu Han, 1 Xianghua Qi, 3 Xiao Ding 3 1 First Clinical Medical College, Shandong University of Traditional Chinese Medicine, Jinan, People's Republic of China; 2 School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, People's Republic of China; 3 Department of Neurology II, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, People's Republic of China Correspondence: Yinqin Liu; Xiao Ding, Email ; Objective: Migraine is a common neurological disorder, which resulting in significant societal and personal burdens. Acupuncture has attracted widespread attention in migraine prophylaxis and treatment in recent years. Although some studies have confirmed the effectiveness of acupuncture therapy in treating migraines, there is still a lack of comprehensive evaluation regarding the comparison between different types of migraines and various acupuncture therapies. Furthermore, certain special acupuncture methods have not received sufficient attention and research. Therefore, the objective of this study is to summarize and expand upon previous research, update existing evidence, and compare the efficacy of different acupuncture therapies for migraine. We aim to provide stronger evidence-based support for clinical practice through this study, thereby promoting wider application of acupuncture therapy in migraine treatment. Methods: A exhaustive and methodical search was conducted across the nine databases: PubMed, EMBASE, Web of Science, Scopus, the Cochrane Library, CBM, CNKI, WANFANG and VIP Data. The Visual Analog Scale (VAS) scores, migraine attack frequency, duration, days of attack and adverse effects were observation indicators. Results: This study included 34 studies involving a total of 3365 migraineurs. The results of the study demonstrated that acupuncture therapy reduced VAS scores of migraine patients better compared to medication (MD=− 1.29, 95% CI=[− 1.67,-0.92]) and exhibited greater efficacy in reducing the frequency of migraine attacks (MD=− 1.95, 95% CI=[− 3.06,-0.85]), the duration of attacks (MD=- 3.29, 95% CI=[− 4.65,-1.93]), and days of attack (MD=− 1.02, 95% CI=[− 1.58,-0.47]). Significant heterogeneity suggested that different acupuncture therapies had varying effects, and that the efficacy of the same therapy may also vary in different migraine types. In the context of network meta-analysis, the SUCRA of acupuncture therapies for reducing VAS scores was ranked as special acupuncture method (98.3%), acupuncture plus medicine (71.9%), and acupuncture (54.5%). Blood-letting and cupping was the most effective treatment for lowering the frequency of migraine attacks. The most effective treatment for shortening the duration of migraine was acupuncture plus medication (81.2%). When it comes to decreasing the days of migraine, acupuncture (80.3%) came out on top. 14 studies reported the occurrence of adverse effects, of which 4 studies had no adverse effects in the test group. Conclusion: Initial findings indicate that acupuncture-related therapy exhibits superior effectiveness in the treatment of migraine and clinical decision-making should be patient-specific. Keywords: acupuncture, migraine, systematic review, network meta-analysis Migraine, one of a disabling primary headache illness, which typically characterised by recurrent moderate or severe unilateral pulsatile headaches, but can also be seen bilaterally. 1 It's usually lasts from a few hours to several days, can be accompanied by nausea and vomiting, and physical activity, light, sound or odor stimulation can aggravate the headache. It is the second most common of the neurological disorders in causing disability-adjusted life-years (DALYs; the sum of years of life lost (YLLs) and years lived with disability (YLDs)) and second only to stroke. 2 Besides, migraine usually affects patients during the ages of 15–49 years, with a peak in prevalence between ages 35 and 39 years. 3 Migraine not only presents headache symptoms, but is also a potential risk factor for ischemic stroke, and is prone to concomitant mental disorders such as anxiety and depression. 4 In the International Classification of Headache Disorders, 3rd edition, ICHD-3, migraine is categorized into six types: migraine without aura, migraine with aura, chronic migraine, migraine complications, probable migraine, and cyclical syndromes that may be associated with migraines, of which the most common is migraine without aura. In addition, the ICHD-3 appendix includes other migraine types that have yet to be further studied and validated, such -Abstract Truncated-
clinical neurology